Clinical Trial Update: National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent

View source ↗

Summary

Clinical trial update on first-line tyrosine kinase inhibitor therapy for adolescent and young adult patients with chronic myeloid leukemia. The current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Status: UNKNOWN